The Dedham Group provides US market access strategic consulting services for oncology & specialty therapeutics life sciences organizations
Research, Analytics, & Strategic Consulting Services
Strategic Access & Value Enhancement Decision Support Tools
Our consistent and unprecedented growth owes in large part to our philosophy of commitment to support each individual in achieving their career and life objectives.
Our team is a select unit of highly structured, deeply analytical, and highly creative individuals typically developed to advance from junior to senior levels professionally from within, consistent with our autonomous culture of innovative thinking, collaboration, specialization, and entrepreneurialism.
Our Dedham Group consultancy and our wholly-owned life sciences analytics and software development business, Pulse, together enable distinct cross-fertilization of thinking to address the pharmaceutical and biotech industry’s mounting challenge to achieve more, in an increasingly complex and rapidly evolving health care environment, yet with fewer resources.
With an inventive, solution-oriented purpose amid heightening competitive intensity in the oncology and specialty arena, we address emerging strategic challenges facing manufacturers through our proprietary structured approaches and processes, while sharing a common commitment enriched by the many unique talents of our individuals, which we celebrate.
Our philosophy centers on our commitment to our people and our trusted relationships—employees, network, and clients—one extended team.
One simple philosophy: always do the right thing and it will come back to us.
When our team member is successful in their role, our projects exceed expectations and add greater value.
When our national panel members of access influencers with whom we’ve built trusted relationships over many years are equipped with objective perspective to succeed in their pursuits owing to our shared view on industry developments, the reliability of our insights and strategic direction as environmental changes unfold will inform better client decision-making.
When we proactively support each client individual to excel relative to their role and responsibility, the pharmaceutical and biotech organization will enjoy sustained success in exceeding their business and corporate objectives.
Against a backdrop of fierce integrity and shared values, we invest considerably in our people who, in turn, invest in the Dedham Group, and thus we are exceedingly selective in whom we welcome into the Dedham Group family. Therein lies the basis for our first decade of unparalleled growth.
Our philosophy prioritizes the growth of our people, who continue their careers with the Dedham Group far longer than industry averages for the consulting industry for this reason. Banded together in our model, our people have consistently exceeded their professional expectations.
Our relationship driven-approach has allowed us to build an unmatched network of oncology and specialty therapeutics access influencers to maintain our robust proprietary dataset in areas typified by a lack of transparency for significant competitive advantage.
The investment we make in each individual has driven the breadth and depth of our client relationships for greater client success that translates into our success via earned loyalty and shared long-term partnerships that make for predictable high-impact achievement and growth of persons and organizations, alike.